Literature DB >> 21674250

Stromal expression of CD34, α-smooth muscle actin and CD26/DPPIV in squamous cell carcinoma of the skin: a comparative immunohistochemical study.

Ayper Kacar1, Ata Türker Arikok, Tuba Dilay Kokenek Unal, Evrim Onder, Sema Hucumenoglu, Murat Alper.   

Abstract

Invasion pathogenesis is one of the most complicated issues in the literature. There are numerous studies concerning the tumor markers implicated in the preinvasive-invasive tumor sequence. Despite ample studies on the invasion pathogenesis of cutaneous melanomas, there is limited and dispersed work presently available on non-melanoma skin cancer. The vast knowledge in the literature concerning this issue in squamous cell carcinoma comes mostly from the studies of the oral cavity, esophagus, larynx, and cervix. In this study, we investigated tumor-free neighboring stroma and tumor stroma in squamous cell carcinomas (SCCs) of the skin as well as keratoacanthomas (KAs) with respect to the presence of stromal CD34-positive (CD34+) fibrocytes and α-smooth muscle actin-positive (α-SMA+) myofibroblasts using seborrheic keratosis (SKs) and non-tumoral skin samples as controls. We also evaluated the stromal expression pattern of CD26/DPPIV (CD26), a tumor suppressor gene product that also has immunoregulatory properties. Immunohistochemistry was performed on samples of 31 SCC, 8 KA, 15 SK and 10 non-tumoral skin samples. Peri-tumoral stroma from resection margins was also evaluated. We found that CD34 and α-SMA demonstrated significantly different staining between benign and malignant squamous skin lesions consisting of a loss of CD34+ fibrocytes paralleled by a gain of α-SMA+ myofibroblasts in malignant tumor stroma. Additionally, it was shown that CD26 expression was lower in tumor stroma when compared to that of tumor neighboring stroma. However, we concluded that this finding may be attributable to the solar elastosis areas in the peritumoral tissue, which shows diffuse strong positivity for this marker.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21674250     DOI: 10.1007/s12253-011-9412-9

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  38 in total

Review 1.  Membrane proteases: roles in tissue remodeling and tumour invasion.

Authors:  W T Chen
Journal:  Curr Opin Cell Biol       Date:  1992-10       Impact factor: 8.382

2.  Involvement of DPPIV/CD26 in epithelial morphology and suppressed invasive ability in ovarian carcinoma cells.

Authors:  Hiroaki Kajiyama; Kiyosumi Shibata; Mikio Terauchi; Kazuhiko Ino; Akihiro Nawa; Fumitaka Kikkawa
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

3.  CD34+ fibrocytes in neoplastic and inflammatory pancreatic lesions.

Authors:  Peter J Barth; Schokufe Ebrahimsade; Achim Hellinger; Roland Moll; Annette Ramaswamy
Journal:  Virchows Arch       Date:  2002-02       Impact factor: 4.064

4.  The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices.

Authors:  Giulio Ghersi; Qiang Zhao; Monica Salamone; Yunyun Yeh; Stanley Zucker; Wen-Tien Chen
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

Review 5.  The role of CD26/dipeptidyl peptidase IV in cancer.

Authors:  Pamela A Havre; Masako Abe; Yasuyo Urasaki; Kei Ohnuma; Chikao Morimoto; Nam H Dang
Journal:  Front Biosci       Date:  2008-01-01

6.  Dipeptidylpeptidase IV activities are elevated in prostate cancers and adjacent benign hyperplastic glands.

Authors:  M J Wilson; A R Ruhland; B J Quast; P K Reddy; S L Ewing; A A Sinha
Journal:  J Androl       Date:  2000 Mar-Apr

7.  Inhibitors of dipeptidyl peptidase IV-like activity mediate antifibrotic effects in normal and keloid-derived skin fibroblasts.

Authors:  Anja Thielitz; Robert W Vetter; Bianca Schultze; Sabine Wrenger; Luca Simeoni; Siegfried Ansorge; Klaus Neubert; Jürgen Faust; Petra Lindenlaub; Harald P M Gollnick; Dirk Reinhold
Journal:  J Invest Dermatol       Date:  2007-10-18       Impact factor: 8.551

8.  Rat dipeptidyl peptidase IV (DPP IV) exhibits endopeptidase activity with specificity for denatured fibrillar collagens.

Authors:  F Bermpohl; K Löster; W Reutter; O Baum
Journal:  FEBS Lett       Date:  1998-05-29       Impact factor: 4.124

9.  CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma.

Authors:  T T Kirchmann; V G Prieto; B R Smoller
Journal:  Arch Dermatol       Date:  1994-05

10.  A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells.

Authors:  U V Wesley; A P Albino; S Tiwari; A N Houghton
Journal:  J Exp Med       Date:  1999-08-02       Impact factor: 14.307

View more
  5 in total

1.  Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy.

Authors:  Rosa Barreira da Silva; Melissa E Laird; Nader Yatim; Laurence Fiette; Molly A Ingersoll; Matthew L Albert
Journal:  Nat Immunol       Date:  2015-06-15       Impact factor: 25.606

2.  Recruitment of CD34(+) fibroblasts in tumor-associated reactive stroma: the reactive microvasculature hypothesis.

Authors:  Rebeca San Martin; David A Barron; Jennifer A Tuxhorn; Steven J Ressler; Simon W Hayward; Xiaoyun Shen; Rodolfo Laucirica; Thomas M Wheeler; Carolina Gutierrez; Gustavo E Ayala; Michael Ittmann; David R Rowley
Journal:  Am J Pathol       Date:  2014-04-05       Impact factor: 4.307

3.  Pharmacologically antagonizing the CXCR4-CXCL12 chemokine pathway with AMD3100 inhibits sunlight-induced skin cancer.

Authors:  Seri N E Sarchio; Richard A Scolyer; Clare Beaugie; David McDonald; Felix Marsh-Wakefield; Gary M Halliday; Scott N Byrne
Journal:  J Invest Dermatol       Date:  2013-10-14       Impact factor: 8.551

4.  Morphological and Molecular Characterization of Human Dermal Lymphatic Collectors.

Authors:  Viktoria Hasselhof; Anastasia Sperling; Kerstin Buttler; Philipp Ströbel; Jürgen Becker; Thiha Aung; Gunther Felmerer; Jörg Wilting
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

5.  CD26 expression is attenuated by TGF-β and SDF-1 autocrine signaling on stromal myofibroblasts in human breast cancers.

Authors:  Yoshihiro Mezawa; Yataro Daigo; Atsushi Takano; Yohei Miyagi; Tomoyuki Yokose; Toshinari Yamashita; Chikao Morimoto; Okio Hino; Akira Orimo
Journal:  Cancer Med       Date:  2019-05-29       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.